Welcome to Oxford Technology
The OT(S)EIS Fund - Currently Open for Investment
"I have been thoroughly impressed with the portfolio of investments you have created for me. As well as showing some extremely positive early successes, these investments are also well distributed and in technologies that I would not normally be able to access." - Current Investor in OT(S)EIS
For more than 30 years, Oxford Technology has specialised in investing in start-up and early stage technology companies based near Oxford. Investments in start-up technology companies are notoriously among the highest risk forms of investment. There are so many things which can and do go wrong. But the SEIS scheme greatly reduces the losses on any failures. And the other side of the high risk coin is that the capital gains when things go well can be substantial. And under the SEIS and EIS schemes all such gains are free of tax.
So, Oxford Technology has issued an Information Memorandum seeking to raise funds to be invested, provided good quality opportunities can be found, in SEIS technology start-ups, and then in years 2-3 in follow on EIS investments, in those of the earlier SEIS investees which are developing well.
The fund has begun making investments, but OT(S)EIS remains open to new investors.
Information on this fund, and how to apply, can be found here: OT(S)EIS Information
Oxford Technology also continues to manage four of its previous funds, the Oxford Technology Venture Capital Trusts. These are now fully invested, but information on these funds can be found here: Venture Capital Trusts
VCT Interim Results Announced
The Net Asset Values as at 31st August 2015 have been announced as:
OT1 VCT - 67.8p Dividends to date 52.7p
OT2 VCT - 30.1p Dividends to date 10.5p
OT3 VCT - 105.5p Dividends to date 10.0p
OT4 VCT - 73.6p Dividends to date 27.0p
The Interim Statements are available to download from the VCT section of this website.Wednesday, October 28, 2015
Investee company 'Lightpoint Medical' in the news
Lightpoint Medical, an investee company from the OT(S)EIS fund, has received CE approval for its LightPath imaging system. To read the more about it, please follow this link:Tuesday, October 20, 2015
Investee company 'Animal Dynamics' in the news
One of OT(S)EIS's investee companies, Animal Dynamics, has been featured in the Economist. To read the article, please follow this link:Monday, September 7, 2015
The AGMs for all four Oxford Technology VCTs took place on the 26th of August. All resolutions were passed.
The Proxy Votes were as follows:
Presentations from the AGM are also available below:Wednesday, August 26, 2015
Oxford Technology VCTs - Notice of AGM & Proxy Forms
The Oxford Technology VCTs will hold their AGMs on the 26th August 2015.
For copies of the formal notice and proxy forms, please use the following links:Tuesday, July 21, 2015
Oxford Technology VCTs release Quarterly Updates
The Oxford Technology VCTs have released their quarterly updates for quarter ending 31 May 2015. The unaudited Net Asset Values at that date are as follows:
OT1 VCT - 75p Dividends to date 52.7p
OT2 VCT - 28.6p Dividends to date 10.5p
OT3 VCT - 103.3p Dividends to date 10p
OT4 VCT - 79p Dividends to date 17p, with a further 10p dividend announced for payment on 7th August 2015
For more in depth details, please consult the RNSs using the following links:Thursday, July 16, 2015
Oxford Technology VCTs announce changes to their Boards
The Oxford Technology VCTs have appointed new Directors. They will now have a common board of 4 Directors (Alex Starling, Richard Roth, Robin Goodfellow, and David Livesley).
For more in depth details, please consult the RNSs released today using the following links:Friday, July 03, 2015
Lightpoint Medical wins UKBAA Award for Best Crowdfunding-Angel Investment of the Year
One of OT(S)EIS' Investee Companies has just won this prestigious award. For further details, please visit their LinkedIn page here:
LinkedIn - Lightpoint Medical Thursday, July 02, 2015
VCT Annual Financial Results Announced
The Net Asset Values as at 28th February 2015 have been announced as:
OT1 VCT - 65p Dividends to date 52.7p
OT2 VCT - 27.8p Dividends to date 10.5p
OT3 VCT - 95.6p Dividends to date 10p
OT4 VCT - 66p Dividends to date 17p, with a further 10p dividend announced for payment on 7th August 2015Tuesday, June 30, 2015
OT4 - Sale of Impact Technologies
At close of business on Friday 29 May 2015, Impact Technologies was acquired by Castleton Technologies Plc for £5m. Further details are available in an RNS announcement, viewable here:Monday, June 1, 2015
OT1 - RNS announcement regarding Scancell Share Price
The Directors of Oxford Technology VCT have issued an RNS regarding the recent reduction in Scancell's share price, viewable here:Wednesday, March 25, 2015
Investee company 'Expend' in the news
One of OT(S)EIS's investee companies, Expend, has recently been in the news. To read the article, please follow this link:Thursday, March 12, 2015
WARNING - e-mail Scam
It has been brought to our attention that e-mails are being sent out in our name, requesting a payment for an attached invoice. These e-mails are not coming from Oxford Technology. We would recommend that you do not download or open the attachments, and instead delete and ignore the e-mail.
Should you have any queries or concerns, please contact Guy Daws at email@example.comThursday, January 08, 2015
VCT 3rd Quarter Results Announced
The Net Asset Values as at 30th November 2014 have been announced as:
OT1 VCT - 72p Dividends to date 52.7p
OT2 VCT - 27p Dividends to date 10.5p
OT3 VCT - 100p Dividends to date 10p
OT4 VCT - 68p Dividends to date 17pTuesday, December 23, 2014
VCT Interim Results Announced
The Net Asset Values as at 31st August 2014 have been announced as:
OT1 VCT - 68p Dividends to date 52.7p
OT2 VCT - 27p Dividends to date 10.5p
OT3 VCT - 98p Dividends to date 10p
OT4 VCT - 73p Dividends to date 17p
The Interim Statements are available to download from the VCT section of this website.Tuesday, October 21, 2014
HMRC confirms continuation of VCT Status OT1 and OT3
Shareholders will be aware from an RNS on 13 March 2014 that Oxford Technology VCT Plc and Oxford Technology 3 VCT Plc (OTVCT)had received notice that Her Majesty's Revenue and Customs ("HMRC") had withdrawn VCT approval for the Company due to a purchase of shares in Scancell Holdings Plc ("Scancell") which HMRC considered as breaching the VCT rules.
Following analysis and representations by OTVCT's legal advisors, Joseph Hage Aaronson LLP ("JHA") and Jonathan Bremner of Counsel, HMRC notified OTVCT that it had set aside that decision pending further review (see RNS of 6 June 2014). Subsequently, following further representations by our legal advisors, HMRC indicated that it was reserving its position and that corrective action was required to be taken in order for OT VCT to retain VCT status (see announcement to shareholders of 5 August 2014). A proposal for the necessary corrective action was made by JHA on 12 August 2014. On 5 September 2014, HMRC indicated that it would be minded to permit the VCT to retain its VCT status for tax purposes provided that the corrective steps proposed by JHA were taken within an agreed timescale.
Following this indication, we have continued to work together with HMRC towards a satisfactory conclusion. We are now pleased to be able to confirm that the corrective steps proposed by our legal advisors have been successfully completed and HMRC have been so informed. We have received formal acknowledgement from HMRC that the corrective action taken has been sufficient and that OT VCT will now retain VCT status going forward subject to continued compliance with VCT rules.
This means that the tax reliefs previously given to the VCT and its shareholders will not be disturbed, and the entitlement to benefit from future reliefs available to VCTs will likewise continue.
Following the corrective action, the VCT's holding in Scancell is now as it was prior to July 2013. The corrective action undertaken has resulted in no financial gain or loss to the VCTs.
We wish to record our appreciation for the constructive way in which HMRC have engaged with us during the last six months. We also wish to thank Joseph Hage Aaronson LLP and Jonathan Bremner for their pro-active and professional work, which has enabled this matter to be brought to its satisfactory conclusion.
The Directors look forward to being able to focus future discussions with shareholders on the progression of the portfolio. As shareholders will be aware from reading the Annual Report, the OT1 portfolio contains some exciting (if still relatively early stage) companies, and the Directors continue to focus on generating maximum value for shareholders from OT VCT's holdings in these.
The content of this RNS has been approved by HMRC.Friday, September 12, 2014